TRex Bio, Inc. (TRXB)

TRex Bio will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

TRex Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	0	-	39.11
Revenue Growth	-	-	-
Gross Profit	0	-	39.11
Selling, General & Admin	-	8.04	6.5
Research & Development	-	29.81	34.99
Operating Expenses	-	37.85	41.49
Operating Income	-49.64	-37.85	-2.38
Interest Expense (Income)	-3.34	-3.15	-2.01
Other Expense (Income)	0.01	0.07	0.07
Pretax Income	-46.3	-34.76	-6.19
Income Tax	0.09	0.05	2.7
Net Income	-46.39	-34.81	-3.14
Preferred Dividends	0	-	5.75
Net Income Common	-46.39	-34.81	-8.89
Net Income Growth	-	-	-

Additional Metrics

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-46.31	-41.43	-25.65
Free Cash Flow Growth	-	-	-
Gross Margin	-	-	100.00%
Operating Margin	-	-	-6.09%
Profit Margin	-	-	-22.73%
Free Cash Flow Margin	-	-	-65.59%
EBITDA	-51.64	-39.46	-7.53
EBITDA Margin	-	-	-19.25%
Depreciation & Amortization	-2	-1.55	0.67
EBIT	-49.65	-37.91	-8.2
EBIT Margin	-	-	-20.96%